?ANCILLARY SERVICES GROUP The Ancillary Services Group (ASG) will provide centralized support across the Disease-Specific Groups and studies for provision of materials for laboratory testing, sample tracking, and assay data transfer from central/mechanistic laboratories except for the Immune Tolerance Network (ITN), which is handled by a different contract. Through the management of a subcontractor for specimen collection supplies, Rho has provided operational support for 2 DAIT-funded consortia ? Clinical Trials in Organ Transplantation (CTOT) and Clinical Trials in Organ Transplantation in Children (CTOT-C), as well as the Scleroderma Cyclophosphamide or Transplantation (SCOT) study funded under the Autoimmune Disease Clinical Trials (ADCT) project. Rho currently uses 2 sample tracking systems, Sampleminded or RhoLAB?, to manage the collection, shipping, and tracking of biological specimens, environmental samples, and other materials collected in DAIT mechanistic studies and clinical trials. Sampleminded is commercial software with a monthly subscription fee per user that has been successfully used on over 30 DAIT-sponsored studies across consortia, including CTOT/CTOT-C, ITN and the Clinical Islet Transplantation (CIT) Consortium. RhoLAB? is a proprietary, in-house system that has been successfully employed for over 20 DAIT-sponsored studies across consortia, including Atopic Dermatitis Research Network (ADRN) and ADCT. The goals of the ASG are to provide consistency across Disease-Specific Groups and studies through standardized processes, and facilitate integration of methodology and practices at study levels conducted by the consortia and to facilitate open lines of communication between each Disease-Specific Group and NIH project office(s) in setting priorities and timelines. Rho proposes to achieve these goals through the use of common tools, processes and reports across the Disease-Specific Groups to allow for more efficient tracking, reconciliation, and analysis of specimen/assay data.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Program Project or Center with Complex Structure Cooperative Agreement (UM2)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-PA-I (J2))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Rho Federal Systems Division, Inc.
Chapel Hill
United States
Zip Code
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138
Gill, Michelle A; Liu, Andrew H; Calatroni, Agustin et al. (2018) Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol 141:1735-1743.e9
Wildfire, Jeremy; Bailey, Ryan; Krouse, Rebecca Z et al. (2018) The Safety Explorer Suite: Interactive Safety Monitoring for Clinical Trials. Ther Innov Regul Sci 52:696-700
Simpson, Eric L; Villarreal, Miguel; Jepson, Brett et al. (2018) Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. J Invest Dermatol 138:2224-2233
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Gergen, Peter J; Mitchell, Herman E; Calatroni, Agustin et al. (2018) Sensitization and Exposure to Pets: The Effect on Asthma Morbidity in the US Population. J Allergy Clin Immunol Pract 6:101-107.e2
du Toit, George; Sayre, Peter H; Roberts, Graham et al. (2018) Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort. J Allergy Clin Immunol 141:1343-1353
Hoch, Heather E; Calatroni, Agustin; West, Joseph B et al. (2017) Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index. J Allergy Clin Immunol 140:1130-1137.e5
Khoury, Samia J; Rochon, James; Ding, Linna et al. (2017) ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. Mult Scler 23:686-695
Li, S; Villarreal, M; Stewart, S et al. (2017) Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis. Br J Dermatol 177:e125-e127

Showing the most recent 10 out of 33 publications